| abstract |
Methods and formulations for reducing high levels of lipids and apolipoprotein B in subjects with type IIb hyperlipidemia. Methods for preventing, delaying or reversing complications of lipid disorders including type IIb hyperlipidemia, NAFLD, and NASH. A method for preventing or delaying primary and secondary cardiovascular events. A kit useful for such methods. How to reduce liver fibrosis. A method of reducing plasma fibrinogen levels. |